EMERGING TRENDS IN NOVEL DRUG DELIVERY SYSTEMS FOR ENHANCED BIOAVAILABILITY AND TARGETTED DRUG ACTION

Naresh Rapi

Rapi Naresh Priyadarshini Institute of Pharmaceutical Education and Research, 5th Mile, Pulladigunta, Guntur-522017, Andhra Pradesh, India.

Abstract

Plants possess medicinal properties and are utilized by humans. Since ancient times, soil has served as both food and medicine. In the contemporary world, the exploration of herbs within laboratory settings, along with preliminary testing and subsequent analysis, has proven beneficial for drug users. This progress has paved the way for the production of herbal products through advancing technology. Recent advancements in our understanding of the pharmacokinetics and pharmacodynamics of drugs offer a more rational basis for creating optimal drug delivery systems. It is clear that collaborative efforts across various disciplines will be crucial for the future success of drug delivery research. Through the implementation of sophisticated techniques, it is feasible to achieve protection against toxicity, enhance stability, improve bioavailability, and safeguard against both chemical and physical degradation of herbal formulations, all of which must yield results in a more efficient or expedited manner. Although traditional medication delivery methods are widely utilized, they are less effective compared to more innovative and modern drug delivery technologies. If the concentration of a drug falls outside the appropriate range, it can either be detrimental or fail to provide any therapeutic benefit. The approach to delivering medications to targeted tissues is becoming increasingly essential, especially given the relatively limited progress in treating severe diseases effectively.

Keywords: Drug delivery system, target site, drug, drug carrier, therapeutic dose, pharmacological effect

Downloads

Download data is not yet available.

References

1. Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP. Novel drug delivery system: an immense hope for diabetics. Drug Deliv. 2016;23(7):2371-2390. doi:10.3109/10717544.2014.991001.
2. Jasmine D. Novel drug delivery system: brief review. J Drug Deliv Ther. 2023;13(12). doi:10.22270/jddt.v13i11.6023.
3. Maravajhala V, Papishetty S, Bandlapalli S. Nanotechnology in development of drug delivery system. Int J Pharm Sci Res. 2012;3(1):84-96.
4. Mirzavi F, Barati M, Soleimani A, Vakili-Ghartavol R, Jaafari MR, Soukhtanloo M. A review on liposome-based therapeutic approaches against malignant melanoma. Int J Pharm. 2021;599:120413. doi:10.1016/j.ijpharm.2021.120413.
5. Wang G, Li R, Parseh B, Du G. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review. Carbohydr Polym. 2021;268:118192. doi:10.1016/j.carbpol.2021.118192.
6. Watson DS, Endsley AN, Huang L. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine. 2012;30(13):2256-2272. doi:10.1016/j.vaccine.2012.01.070.
7. Man F, Gawne PJ, de Rosales RT. Nuclear imaging of liposomal drug delivery systems: a critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev. 2019;143:134-160. doi:10.1016/j.addr.2019.05.012.
8. dos Santos Rodrigues B, Banerjee A, Kanekiyo T, Singh J. Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection. Int J Pharm. 2019;566:717-730. doi:10.1016/j.ijpharm.2019.06.026.
9. Taha EI, El-Anazi MH, El-Bagory IM, Bayomi MA. Design of liposomal colloidal systems for ocular delivery of ciprofloxacin. Saudi Pharm J. 2014;22(3):231-239. doi:10.1016/j.jsps.2013.07.003.
10. Han Y, Gao Z, Chen L, Kang L, Huang W, Jin M, et al. Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins. Acta Pharm Sin B. 2019;9(5):902-922. doi:10.1016/j.apsb.2019.01.004.
11. Mirtaleb MS, Shahraky MK, Ekrami E, Mirtaleb A. Advances in biological nano-phospholipid vesicles for transdermal delivery: a review on applications. J Drug Deliv Sci Technol. 2021;61:102331. doi:10.1016/j.jddst.2021.102331.
12. Mehta PP, Ghoshal D, Pawar AP, Kadam SS, Dhapte-Pawar VS. Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance. J Drug Deliv Sci Technol. 2020;56:101509. doi:10.1016/j.jddst.2020.101509.
13. Yusuf H, Ali AA, Orr N, Tunney MM, McCarthy HO, Kett VL. Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine. Int J Pharm. 2017;533(1):179-186. doi:10.1016/j.ijpharm.2017.09.017.
14. Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851. doi:10.1016/j.addr.2021.113851.
15. Corace G, Angeloni C, Malaguti M, Hrelia S, Stein PC, Brandl M, et al. Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride. J Liposome Res. 2014;24(4):323-335. doi:10.3109/08982104.2014.899369.
16. Vert M, Doi Y, Hellwich KH, Hess M, Hodge P, Kubisa P, et al. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). Pure Appl Chem. 2012;84(2):377-410. doi:10.1351/PAC-REC-10-12-04.
17. Kammari R, Das NG, Das SK. Nanoparticulate systems for therapeutic and diagnostic applications. In: Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices. Oxford: Elsevier; 2017. p. 105-144. doi:10.1016/B978-0-323-42978-8.00006-1.
18. Katakam P, Dey B, Assaleh FH, Hwisa NT, Adiki SK, Chandu BR, et al. Top-down and bottom-up approaches in 3D printing technologies for drug delivery challenges. Crit Rev Ther Drug Carrier Syst. 2015;32(1):61-87. doi:10.1615/CritRevTherDrugCarrierSyst.2014011157.
19. Assaleh FH, Katakam P, Botcha R, Chandu BR, Adiki SK. Synthesis and characterisation of starch tartrate and its application as novel disintegrant in telmisartan tablets. Starch/Stärke. 2014;66(3-4):409-417. doi:10.1002/star.201300136.
20. Ravilla S, Chandu BR, Nama S. Erythrocytes as carrier for drugs, enzymes and peptides. J Appl Pharm Sci. 2012;2(5):166-176. doi:10.7324/JAPS.2012.2503.
21. Prakash K, Awen BZ, Rao CB, Kumari AS. Fabrication and in vitro evaluation of subgingival strips of calcium alginate for controlled delivery of ofloxacin and metronidazole.
22. Katakam P, Diaf SR, Dey B, Adiki SK, Chandu BR, Chowdary KP. A comparative evaluation of drug release and permeability of ethylcellulose, cellulose acetate and Eudragit RS100 microspheres. Int J Sci Res Knowl. 2014;2(2):75-82. doi:10.12983/ijsrk-2014-p0075-0082.